Renal toxicities of chemotherapy

Seminars in Oncology

Volumn 33, Issue 1, 2006, Pages 68-73

  De Jonge, Maja J A ^a   Verweij, Jaap ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; CARBOPLATIN; CARBOXYPEPTIDASE G2; CISPLATIN; CYCLOPHOSPHAMIDE; DIAZIQUONE; DRUG METABOLITE; FOLINIC ACID; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; MITOMYCIN; OXALIPLATIN; PENTOSTATIN; STREPTOZOCIN; VINCRISTINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; AMINOACIDURIA; ANEMIA; BLEEDING; BRAIN TUMOR; CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CREATININE BLOOD LEVEL; EVALUATION; FANCONI RENOTUBULAR SYNDROME; FEVER; GLUCOSURIA; GROWTH RETARDATION; HEMODIALYSIS; HUMAN; HYPERBILIRUBINEMIA; HYPERTENSION; HYPOKALEMIA; HYPOPHOSPHATEMIA; KIDNEY FUNCTION; KIDNEY TUBULE ACIDOSIS; KIDNEY TUBULE DAMAGE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKEMIA; LUNG EDEMA; NAUSEA; NEPHROTOXICITY; NEUROLOGIC DISEASE; NONHUMAN; OSTEOMALACIA; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RICKETS; RISK FACTOR; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; UREMIA; VOMITING;

EID: 32244440193     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2005.11.011     Document Type: Article

References (49)

1. K.H. Rahn, S. Heindenreich, D. Brückner How to assess glomerular function and damage in humans J Hypertens 17 1999 309 317
2. P.D. Doolan, E.L. Alpen, G.B. Theil A clinical appraisal of the plasma concentration and endogenous clearance of creatinine Am J Med 1962 65 79
3. 99m DTPA clearance) in cancer patients Ann Oncol 13 2002 949 955
4. G. Daugaard, U. Abildgaard Cisplatin nephrotoxicity Cancer Chemother Pharmacol 25 1989 1 9
5. A.H. Lau Apoptosis induced by cisplatin nephrotoxic injury Kidney Int 56 1999 1295 1298
6. I. Arany, R.L. Safirstein Cisplatin nephrotoxicity Semin Nephrol 23 2003 460 464
7. R. Kroning, D. Katz, A.K. Lichtenstein Differential effects of cisplatin in proximal and distal renal tubule epithelial cell lines Br J Cancer 79 1999 293 299
8. S. Osanto, A. Bukman, F. Van Hoek Long-term effects of chemotherapy in patients with testicular cancer J Clin Oncol 10 1992 574 579
9. P.E. Kintzel Anticancer drug-induced kidney disorders Drug Saf 24 2001 19 38
10. F.N. Hutchison, E.A. Perez, D.R. Gandara Renal salt wasting in patients treated with cisplatin Ann Intern Med 108 1985 21 25
11. D.R. Bell, R.L. Woods, J.A. Levi cis-Diamminedichloroplatinum-induced hypomagnesemia and renal magnesium wasting Eur J Cancer Clin Oncol 21 1985 287 290
12. P.R. Watson, T.H. Guthrie Jr, R.J. Caruana Cisplatin-associated hemolytic-uremic syndrome Cancer 64 1989 1400 1403
13. D.M. Hayes, E. Cvitkovic, R.B. Golbey High dose cisplatinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis Cancer 39 1977 1372 1381
14. S.D. Forrester, E.A. Fallin, G.K. Saunders Prevention of cisplatin-induced nephrotoxicosis in dogs, using hypertonic saline solution as the vehicle of administration Am J Vet Res 54 1993 2175 2178
15. R.F. Ozols, B.J. Corden, J. Jacob High-dose cisplatin in hypertonic saline Ann Intern Med 100 1984 19 24
16. S. Aamdal, Ø. Fodstad, O. Kaalhus Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle J Natl Cancer Inst 73 1984 743 752
17. M.H. Hanigan, M. Deng, L. Zhang A small increase in the Na ion concentration inhibits cisplatin toxicity in culture Proc Am Assoc Cancer Res 43 2002 423 424 (abstr 2106)
18. A.M. Osman, E.M. El-Sayed, E. El-Demerdash Prevention of cisplatin-induced nephrotoxicity by methimazole Pharmacol Res 41 2000 115 121
19. K. Mishima, S. Hidaka, N. Takamura Protection against cis-diamminedichloroplatinum-induced nephrotoxicity by 2,3-dimercaptosuccinic acid in rats Renal Fail 21 1999 593 602
20. T. Nakamura, T. Kokuryo, Y. Hashimoto Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats J Pharm Pharmacol 51 1999 227 232
21. L.M. Greggi Antunes, J.D. Darin, M.D. Bianchi Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats A dose-dependent study Pharmacol Res 41 2000 405 411
22. S.Y. Saad, T.A. Najjar, M.O. Al-Sohaibani The effect of rebamipide on cisplatin-induced nephrotoxicity in rats Pharmacol Res 42 2000 81 86
23. S.M. Somani, K. Husain, C. Whitworth Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats Antioxidant defense system Pharmacol Toxicol 86 2000 234 241
24. M. Naziroǧlu, A. Karaoǧlu, A.O. Aksoy Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal liver and lens tissues in rats Toxicology 195 2004 221 230
25. J.M. Berry, C. Jacobs, B. Sikic Modification of cisplatin toxicity with diethyldithiocarbamate J Clin Oncol 8 1990 1585 1590
26. G. Kemp, P. Rose, J. Lurain Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities Results of a randomized control trial in patients with advanced ovarian cancer J Clin Oncol 14 1996 2101 2112
27. A.S. Planting, G. Catimel, P.H. De Mulder Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer EORTC Head and Neck Cooperative Group Ann Oncol 10 1999 693 700
28. J.R. Hardy, S. Tan, I. Fryatt How nephrotoxic is carboplatin? Br J Cancer 61 1990 644
29. J. Cassidy, J.-L. Misset Oxaliplatin-related side effects Characteristics and management Semin Oncol 29 2002 11 20
30. T.J. Stillwell, R.C. Benson Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients Cancer 61 1988 451 457
31. M. Zalupski, L.H. Baker Ifosfamide J Natl Cancer Inst 80 1988 556 566
32. T. Kerbush, J. De Kraker, J. Keizer Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites Clin Pharmacokinet 40 2001 41 62
33. J.M. Hows, A. Mehta, L. Ward Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation A prospective randomised study Br J Cancer 50 1984 753 756
34. J.D. Shepherd, L.E. Pringle, M.J. Barnett Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation J Clin Oncol 9 1991 2016 2020
35. M.P. Goren, J.M. Houle, D.A. Bush Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects Clin Cancer Res 4 1998 2313 2320
36. R. Skinner, I.M. Sharkey, A.D. Pearson Ifosfamide, mesna, and nephrotoxicity in children J Clin Oncol 11 1993 173 190
37. J.S. McCune, D.L. Friedman, S. Schuetze Influence of age upon ifosfamide-induced nephrotoxicity Pediatr Blood Cancer 42 2004 427 432
38. R. Skinner Chronic ifosfamide nephrotoxicity in children Med Pediatr Oncol 41 2003 190 197
39. T. Langer, L.T. Stohr, S. Bielack Late effects surveillance system for sarcoma patients 42 2004 373 379
40. R.G. Schacht, H.D. Feiner, G.R. Gallo Nephrotoxicity of nitrosoureas Cancer 48 1981 1328 1334
41. W.E. Harmon, H.J. Cohen, E.E. Schneeberger Chronic renal failure in children treated with methyl CCNU N Engl J Med 300 1979 1200 1203
42. J.E. Cantrell Jr, T.M. Phillips, P.S. Schein Carcinoma-associated hemolytic-uremic syndrome A complication of mitomycin C chemotherapy J Clin Oncol 3 1985 723 734
43. H.W. Snyder Jr, A. Mittelman, A. Oral Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma Cancer 71 1993 1882 1892
44. K. Lhotta, T. Kühr, H. Rumpelt Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy Am J Nephrol 19 1999 590 593
45. H.T. Abelson, M.T. Fosburg, P. Beardsley Methotrexate-induced renal impairment clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine J Clin Oncol 1 1983 208 216
46. B.C. Widemann, F.M. Balis, B. Kempf-Bielack High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma Cancer 100 2004 2222 2232
47. J. Margolis, M.R. Grever Pentostatin (Nipent) A review of potential toxicity and its management Semin Oncol 27 2000 9 14
48. A.-M. Tsimberidou, F. Giles, M. Duvic Phase II study of pentostatin in advanced T-cell lymphoid malignancies Cancer 100 2004 342 349
49. H.O. Cutting Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy Am J Med 51 1971 269 271